Issue 40, 2014

Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy

Abstract

Fluorescent and biotinylated squalene–gemcitabine prodrug nanoparticles exhibiting high drug payloads have been prepared and successfully used to target different cancer cell lines, resulting in increased cell uptake and improved anticancer efficiency, which represents the first targeted system derived from the squalenoylation approach.

Graphical abstract: Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
28 9 2013
Accepted
17 10 2013
First published
18 10 2013

Chem. Commun., 2014,50, 5336-5338

Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy

D. T. Bui, J. Nicolas, A. Maksimenko, D. Desmaële and P. Couvreur, Chem. Commun., 2014, 50, 5336 DOI: 10.1039/C3CC47427E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements